This session examines where the inefficiencies are, what's actually changing, and what a best-in-class development program looks like today. The adoption gap is just as important: designing a trial without thinking about how the product will be used in practice builds in a commercialization problem from day one.
- Where the biggest time and cost sinks in trial design are structural versus fixable
- Real-world evidence and PIMS data as a supplement to traditional clinical trials
- What regulators, acquirers, and licensees actually need from your data package
- Designing for adoption: building clinical utility and practice-readiness from the start
- The CRO landscape: what's available, what's missing, and where the bottlenecks are
Speaker(s):
Moderator

Rebecca Windsor
Director of Veterinary Affairs
Gallant
Panelists

Tommy Jackson
Chief Executive Officer
Prelude

Cheryl London
Director of Clinical Research
Tufts University, Cummings School of Veterinary Medicine

Christina Lopes
Co-Founder and CEO
FidoCure
Time:
3:00pm-3:30pm
Agenda Track No.:
Track 8
Summary:
Session Credits: 1.0
Session Type:
General Session (Presentation)
Force Inline Description:
0